CD8A and neoplasm: Furthermore, administration of EGCG was able to partly restore the percentages of CD4+ T helper cells and CD8+ cytotoxic T cells in the spleen and tumor tissues (Figure 3A–D), indicating the anti-tumor immune response in tumor-bearing mice is enhanced by EGCG treatments.